ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1909–1920 of 2020 project topics
Bone Marrow Failure Syndrome Genetic Database Licensing Portal
A continuously updated clinical database aggregating pathogenic variants, population frequencies, and phenotypic correlations specific to bone marrow failure syndromes for research and diagnostic validation. Diagnostic labs, pharmaceutical companies, and CROs license access to this proprietary database to accelerate variant interpretation and support clinical trial patient stratification.
Genetic Basis of Bone Marrow Failure Syndromes Click to view more details →
RUNX1 and MPL Familial Platelet Disorder Predictive Model
A machine learning model that predicts leukemia transformation risk in patients carrying RUNX1 or MPL mutations based on integrated genetic and clinical phenotyping data. Medical centers implement this prognostic tool to guide personalized monitoring protocols and treatment escalation, creating licensing opportunities and outcomes-based service contracts.
Genetic Basis of Bone Marrow Failure Syndromes Click to view more details →
AMD Complement and CFH Genetic Risk Testing
Characterizing complement factor H and CFI genetic risk variants for AMD susceptibility and studying gene-environment interaction with smoking.
Genetic Basis of Complex Eye Diseases Click to view more details →
Glaucoma GWAS Signal Functional Characterization
Investigating functional mechanisms of top GWAS signals for primary open-angle glaucoma at CDKN2B-AS1, TMCO1, and CAV1/CAV2 loci.
Genetic Basis of Complex Eye Diseases Click to view more details →
Diabetic Retinopathy Genetic Risk Factors
Identifying genetic variants modifying diabetic retinopathy risk beyond glycemic control for improving personalized screening intensity recommendations.
Genetic Basis of Complex Eye Diseases Click to view more details →
Myopia Genetic Architecture Studies
Characterizing genetic architecture of high myopia through GWAS and family sequencing for identifying genes controlling axial eye length.
Genetic Basis of Complex Eye Diseases Click to view more details →
Retinal Dystrophy Pathogenic Variant SaaS Platform
A cloud-based diagnostic platform that identifies and interprets rare pathogenic variants in inherited retinal dystrophy genes through NGS data analysis and variant classification. This enables ophthalmology labs to offer molecular diagnosis services, capturing recurring revenue through subscription tiers and per-test processing fees.
Genetic Basis of Complex Eye Diseases Click to view more details →
Keratoconus Polygenic Risk Score Commercial Tool
A genomic testing service that calculates polygenic risk scores for keratoconus susceptibility using genome-wide SNP data and predictive algorithms. This supports preventive eye care strategies and generates B2B revenue from eye clinics, contact lens manufacturers, and refractive surgery centers seeking patient stratification.
Genetic Basis of Complex Eye Diseases Click to view more details →
Posterior Segment Disease Genetic Counseling Software
An AI-powered software platform that automates genetic counseling workflows for inherited macular and optic nerve diseases, including patient risk assessment and family planning guidance. The tool monetizes through licensing agreements with genetic testing laboratories and ophthalmology hospitals requiring scalable counseling infrastructure.
Genetic Basis of Complex Eye Diseases Click to view more details →
Cataracts Early-Onset Genomic Screening Kit
A commercial genomic screening product targeting pediatric cataracts that identifies monogenic and oligogenic contributors using targeted sequencing panels. Revenue streams include direct-to-consumer testing, institutional partnerships with pediatric eye centers, and licensing intellectual property to diagnostic companies.
Genetic Basis of Complex Eye Diseases Click to view more details →
Stargardt Disease Genotype-Phenotype Prediction Engine
A proprietary bioinformatics tool that predicts disease progression and treatment response in Stargardt disease patients based on ABCA4 variant data and machine learning models. This delivers value to gene therapy companies, clinical trial sponsors, and ophthalmology practices through patient stratification and prognosis insights.
Genetic Basis of Complex Eye Diseases Click to view more details →
Ocular Surface Disease Genetic Biomarker Testing Service
A direct testing service that analyzes genetic variants associated with dry eye disease and Stevens-Johnson syndrome to predict treatment outcomes and severity. Revenue is generated through high-volume test ordering partnerships with optometry networks, dermatology clinics, and pharmaceutical companies conducting biomarker-driven clinical trials.
Genetic Basis of Complex Eye Diseases Click to view more details →